Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders.
about
Consensus paper: pathological role of the cerebellum in autismCytokine dysregulation in autism spectrum disorders (ASD): possible role of the environmentProtective effect of nuclear factor E2-related factor 2 on inflammatory cytokine response to brominated diphenyl ether-47 in the HTR-8/SVneo human first trimester extravillous trophoblast cell lineEnvironmental toxicants and autism spectrum disorders: a systematic reviewDifferential monocyte responses to TLR ligands in children with autism spectrum disorders.The immune system's role in the biology of autism.Autism: an emerging 'neuroimmune disorder' in search of therapy.Modulation of the genome and epigenome of individuals susceptible to autism by environmental risk factorsFMR1 premutation and full mutation molecular mechanisms related to autism.Increased production of IL-17 in children with autism spectrum disorders and co-morbid asthma.Involvement of reactive oxygen species in brominated diphenyl ether-47-induced inflammatory cytokine release from human extravillous trophoblasts in vitroPrenatal exposure to common environmental factors affects brain lipids and increases risk of developing autism spectrum disorders.The plausibility of maternal toxicant exposure and nutritional status as contributing factors to the risk of autism spectrum disorders.Prenatal Serum Concentrations of Brominated Flame Retardants and Autism Spectrum Disorder and Intellectual Disability in the Early Markers of Autism Study: A Population-Based Case-Control Study in California.Immune Abnormalities in Autism Spectrum Disorder-Could They Hold Promise for Causative Treatment?Troxerutin Protects Kidney Tissue against BDE-47-Induced Inflammatory Damage through CXCR4-TXNIP/NLRP3 Signaling.Quantitative Validation and Comparison of Multiplex Cytokine Kits
P2860
Q26830626-11D431C5-4BC3-4144-A421-4929B0353134Q27011394-DB0D7D8A-0D12-46EF-ACC2-0DA6DD8EF06DQ28391645-3B2B5B12-1F3D-46E7-BF53-13BDF03E3AFCQ28397071-BCD2260F-FA85-4FBB-B96F-E38E93E8A354Q30477710-2B0555F4-36F7-49F1-907C-DB13BC88E093Q33966312-352E08D6-6F43-43ED-9D8F-DAA9D16012DAQ34994653-C6FE7CED-D7C8-44B8-8C7C-6B7DD3EC94B9Q35585726-05F7371C-D0A8-40FA-A5E4-E8D0E970BF57Q35680720-B9C44B79-B395-46D6-9646-1288C7776BCBQ35994564-D9DE606A-3BA0-433A-AA3F-AA671F8E439AQ37597142-8ECCA2EF-B701-44DD-89FD-319FEB42E38DQ38555255-E0F950D5-AABC-4657-B9B5-5DD2A7D5771DQ40892251-787DF6D0-CA9C-4259-ACE6-842C5FD62D32Q46166292-B91788E6-5BDF-4B24-BCBC-5EB9FD04C5F6Q47564469-D240E02F-BF45-4556-B056-D0C2FCA7AF3BQ55035321-07D361D8-DB1F-4E3F-9D81-1409AA60B7D3Q57203286-AE73E204-27D8-4F0E-B1AB-C0510F8F2FD9
P2860
Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Preliminary evidence of the in ...... ith autism spectrum disorders.
@en
Preliminary evidence of the in ...... ith autism spectrum disorders.
@nl
type
label
Preliminary evidence of the in ...... ith autism spectrum disorders.
@en
Preliminary evidence of the in ...... ith autism spectrum disorders.
@nl
prefLabel
Preliminary evidence of the in ...... ith autism spectrum disorders.
@en
Preliminary evidence of the in ...... ith autism spectrum disorders.
@nl
P2093
P2860
P1476
Preliminary evidence of the in ...... ith autism spectrum disorders.
@en
P2093
Isaac N Pessah
Joseph Schauer
Judy Van de Water
Paul Ashwood
P2860
P304
P356
10.1016/J.JNEUROIM.2008.12.012
P577
2009-02-10T00:00:00Z